Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy

Chimeric Antigen Receptor (CAR) T-cells are T-cells with recombinant receptors targeted to tumor antigens. CAR-T cell therapy has emerged as a mode of immunotherapy and is now being extensively explored in hematologic cancer. In contrast, CAR-T cell use in solid tumors has been hampered by multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Sridhar, Praveen, Petrocca, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532628/
https://www.ncbi.nlm.nih.gov/pubmed/28718815
http://dx.doi.org/10.3390/cancers9070092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532628/
https://www.ncbi.nlm.nih.gov/pubmed/28718815
http://dx.doi.org/10.3390/cancers9070092

Ejemplares similares